Meditation technique brings peace of mind to breast cancer survivors

An intervention known as mindfulness-based stress reduction (MBSR) showed a trend toward improving psychological outcomes by reducing mood disturbance in women who had survived early-stage breast cancer.

MBSR incorporates meditation, yoga, and physical awareness. In a recent study reported in the Western Journal of Nursing Research (2011;33(8):993-995), nurse researchers at the University of Missouri–Columbia (MU) administered MBSR group sessions over a period of 8 to 10 weeks. During these sessions, the breast cancer survivors practiced meditation skills, discussed how bodies respond to stress, and learned coping techniques.

Compared with a control group that received no MBSR training, participants who learned MBSR experienced statistically significant reductions in blood pressure, heart rate, and respiratory rate; increased their mindfulness state, and experienced improvements in mood.

Although the effects of MBSR on reducing stress were statistically significant on the physiological outcome (morning cortisol) at the measurement after the intervention completion, this effect was not sustained at 1-month follow-up. Coinvestigator and MU professor of nursing Jane Armer recommended in a separate statement that patients practice mindfulness-based meditation every day or at least routinely to garner short- and long-term benefits.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Relapse of diffuse large B-cell lymphoma not detected by imaging scans

Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, according to a new study. The overwhelming majority of patients with this aggressive lymphoma already have symptoms, an abnormal physical examination or an abnormal blood test at the time ...

Late recurrence risk in breast cancer differentiated by gene expression test

Patients at higher or lower risk for having their cancer recur elsewhere in the body more than 5 years after diagnosis can be differentiated by a gene expression test. The test measures the expression levels of 58 genes in estrogen receptor-positive breast cancers. These research ...

Locally advanced pancreatic cancer responds to FOLFIRINOX

FOLFIRINOX chemotherapy plus chemoradiation helped make resection possible in locally advanced pancreatic cancer.